It's way too easy to hack the hospital | Bloomberg Businessweek
"White hat" hacker Billy Rios, who is often called upon to hack health systems' networks and medical devices to test their vulnerabilities, says lax security is rampant and patient safety is at risk. But not everyone is receptive to his warnings. Rios is on a mission to get the FDA and devicemakers to take the risks seriously.
Drug companies underreport clinical trial results. Can a transparency scorecard fix it? | BMJ Open
Many drug companies fail to register or report results of some clinical trials for new drugs, according to a study published Thursday in BMJ Open. Researchers reviewed available trial data for drugs approved in 2012 sponsored by 10 large pharmaceutical companies. Over a third of trial results were not publicly available and a third did not comply with legal disclosure requirements. The researchers suggest an annual transparency scorecard could boost compliance—and they've got one in the works.
Uterus transplants may soon help some women in the U.S. become pregnant | New York Times
The Cleveland Clinic is preparing to become the first in the U.S. to perform uterus transplants for women who would like to give birth but were born without a uterus, have uterine damage or had a hysterectomy. The procedure has only been performed successfully nine times, all by the University of Gothenburg, Sweden.
The Martin Shkreli Show: The widely scorned pharma exec just can't stop talking | STAT
Turing Pharmaceuticals CEO Martin Shkreli, decried by other drug company execs, politicians and the public for buying rights to an old, inexpensive drug for a rare condition and then jacking up the price more than 5000%, thinks he's gotten a bum rap, and the way to fix it is to help America get to know him by broadcasting the most banal moments of his day.
Speaking of pharma villainy, if you've ever wanted to try your own hand at running a pharmaceutical empire, now you can. Enter Big Pharma, a management simulation game that lets players work through all the technical and ethical hurdles of drug development. Martin Shkreli mod available separately.
